Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Clinical trial NCT00120939 · COMPLETED

Trial details

NCT number: NCT00120939
Sponsor: Pharmacyclics LLC.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Neoplasms Ovarian Neoplasms Prostatic Neoplasms Lung Neoplasms Gastrointestinal Neoplasms

Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.